In this article we want to delve deeper into the topic of National Science Advisory Board for Biosecurity, which has aroused great interest in multiple sectors of society. National Science Advisory Board for Biosecurity has gained relevance in recent years due to its significant impact in different areas, from health to technology. Along these lines, we will analyze the most relevant aspects related to National Science Advisory Board for Biosecurity, exploring its importance, its evolution over time and the future perspectives that are envisioned around this topic. From its origins to its current relevance, National Science Advisory Board for Biosecurity has proven to be a turning point that marks a before and after in numerous areas, motivating debates, research and significant changes.
This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (July 2024) |
| Abbreviation | NSABB |
|---|---|
| Location | |
| Membership | Jason Boehm (Department of Commerce) David Christian Hassell (Department of Defense) Sharlene Weatherwax (Department of Energy) Anthony S. Fauci (Department of Health and Human Services) Sally Phillips (Department of Health and Human Services) CAPT Carmen Maher (Department of Health and Human Services) Michael W. Shaw(Department of Health and Human Services) |
The National Science Advisory Board for Biosecurity (NSABB) is a panel of experts that reports to the Secretary of the United States Department of Health and Human Services. It is tasked with recommending policies on such questions as how to prevent published research in biotechnology from aiding terrorism, without slowing scientific progress.[1]
The NSABB is a federal advisory committee that addresses issues related to biosecurity and dual use research at the request of the United States Government. The NSABB has up to 25 voting members with a broad range of expertise including molecular biology, microbiology, infectious diseases, biosafety, public health, veterinary medicine, plant health, national security, biodefense, law enforcement, scientific publishing, and other related fields.[2]
In May 2016,[3] the NSABB published "RECOMMENDATIONS FOR THE EVALUATION AND OVERSIGHT OF PROPOSED GAIN-OF-FUNCTION RESEARCH".[4]
The NSABB had published 11 reports as of February 2021. The first report on the list was released in December 2006.[5]
The NSABB is composed of non-voting ex officio and appointed voting members. As of 2021, the Chair of the NSABB was Gerald W. Parker, Jr., DVM, PhD.[6]
As of 2017, the ex officio members were:[7]
{{cite web}}: CS1 maint: archived copy as title (link)